» Articles » PMID: 6691897

Suppression of Natural Killer Cell Activity by Adherent Effusion Cells of Cancer Patients. Suppression of Motility, Binding Capacity and Lethal Hit of NK Cells

Overview
Journal Br J Cancer
Specialty Oncology
Date 1984 Jan 1
PMID 6691897
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Adherent cells from carcinomatous pleural effusions of lung cancer patients were tested for their ability to suppress natural killer (NK) cell activity, and the mechanism involved in the suppression of NK cell activity was determined. Adherent effusion cells (AEC) were isolated from malignant pleural effusions of patients by centrifugation discontinuous Ficoll-Hypaque gradients and adherence to serum-coated plastic dishes, and large granular lymphocytes (LGL) were purified from the peripheral blood of normal individuals by centrifugation on discontinuous Percoll gradients and further depletion of high-affinity sheep erythrocyte rosette formation. LGL-mediated lysis of K562 cells was suppressed when LGL were cultured with AEC for 20 h, then washed and tested in a 4-h 51Cr release assay. More profound suppression of NK cell activity was observed when cytotoxicity was assayed in flat-bottomed wells rather than in round-bottomed wells. Cytotoxicity assays conducted at the single cell level in agarose revealed that the frequency of LGL binding to K562 cells and of dead conjugated target cells was reduced after overnight contact with AEC. In agarose microdroplet assays, functional LGL from normal donors exhibited definitive motility, expressing polarized shape. In contrast, a small number of LGL with non-polarized configuration migrated from the agarose droplet after overnight culture with AEC. These results indicate that functionally suppressed NK cells lose their motility, binding capacity and killing activity, which could be responsible for the suppression of NK cell activity by AEC.

Citing Articles

Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy.

Poznanski S, Ritchie T, Fan I, El-Sayes A, Portillo A, Ben-Avi R J Immunother Cancer. 2021; 9(1).

PMID: 33479024 PMC: 7825270. DOI: 10.1136/jitc-2020-001933.


Influence of natural killer cells and perforin‑mediated cytolysis on the development of chemically induced lung cancer in A/J mice.

Frese-Schaper M, Keil A, Yagita H, Steiner S, Falk W, Schmid R Cancer Immunol Immunother. 2014; 63(6):571-80.

PMID: 24658838 PMC: 11029497. DOI: 10.1007/s00262-014-1535-x.


Vimentin in cancer and its potential as a molecular target for cancer therapy.

Satelli A, Li S Cell Mol Life Sci. 2011; 68(18):3033-46.

PMID: 21637948 PMC: 3162105. DOI: 10.1007/s00018-011-0735-1.


In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.

Uchida A, Yanagawa E, Kokoschka E, Micksche M, Koren H Br J Cancer. 1984; 50(4):483-92.

PMID: 6237664 PMC: 1976901. DOI: 10.1038/bjc.1984.205.


Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer.

Monson J, Ramsden C, Giles G, Brennan T, Guillou P Gut. 1987; 28(11):1420-5.

PMID: 3501386 PMC: 1433680. DOI: 10.1136/gut.28.11.1420.


References
1.
Savary C, Lotzova E . Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice. J Immunol. 1978; 120(1):239-43. View

2.
Uchida A, Micksche M . Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. Int J Cancer. 1983; 32(1):37-44. DOI: 10.1002/ijc.2910320107. View

3.
Tagliabue A, Herberman R, McCOY J . Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice. Cancer Res. 1978; 38(8):2279-84. View

4.
CUDKOWICZ G, Hochman P . Do natural killer cells engage in regulated reactions against self to ensure homeostasis?. Immunol Rev. 1979; 44:13-41. DOI: 10.1111/j.1600-065x.1979.tb00266.x. View

5.
Grimm E, Bonavida B . Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol. 1979; 123(6):2861-9. View